Patients & ProvidersHow SelfWrap WorksCompanyNewsClinical Trial

Aiming to Improve the Lives of Patients Undergoing Vascular Surgery

About VenoStent

A Clinical-Stage Therapeutic Medical Device Company

We’re a clinical-stage therapeutic medical device company that’s developed finely-tuned, bioabsorbable wraps intended to improve outcomes for the 5 million vascular surgeries performed each year.

A Novel Technology with High Potential

We’re developing a bioabsorbable perivascular wrap, SelfWrap, that goes around arteriovenous (AV) access sites at the time of AV creation surgery. The wrap is intended to improve the usability (i.e. maturation) and durability (i.e. patency) of these sites for chronic kidney disease (CKD) patients requiring hemodialysis. If successful, this could improve the quality of life for CKD patients requiring hemodialysis.

Materials are absorbed by the body, unlike alloy-based products

Finely-Tuned Materials

A conforming fit for each patient

3D-Printed Polymers

Reliably and robustly produced

Numerous Applications

Potential for coronary and peripheral bypass grafting, others


A Cross-Disciplinary Team of Experts

Tim Boire, PhD
Tim Boire, PhD

CEO & Co-founder

Geoff Lucks
Geoff Lucks

COO & Co-founder

Pamela Misajon
Pamela Misajon

Chief Compliance Officer

Mark Barakat, MD
Mark Barakat, MD

Director of Clinical Affairs

Tina McArthur
Tina McArthur

Vice President of Research and Engineering

IAG Capital Partners
Good Growth Capital
Creative Ventures
Baylor Angel Network
TMC Venture Fund
Alumni Ventures
Y Combinator
CowTown Angels
Texas Halo Fund
Activated Capital
Kidney Innovation Accelerator
Houston Methodist
Vanderbilt University
Latest News & Press
Read more news

SelfWrap is currently in the research and development phase and is not available for sale in any country. Investigational Device. Limited by Federal Law to Investigational Use.

COI Policy© 2024 VenoStent, Inc. All rights reserved.
2450 Holcombe Blvd, Suite J Houston, TX 77021
Follow Us